Vladimir Ioffe, MD
Dear USPSTF: Don’t discount value of PSA in men 70+
“We strongly believe that PSA-based prostate cancer screening should be made available, especially to men 70 years and older to decrease the morbidity and mortality of prostate cancer,” write Navin Shah, MD, and Vladimir Ioffe, MD.


View Results